Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 1 25Phase 1/2 22Phase 3 10Phase 2/3 3Phase NA 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 19Lymphoma 12Leukemia 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 5Myeloproliferative Disorders 4Hodgkin Disease 4Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Congenital Abnormalities 3Sezary Syndrome 2Neoplasms 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Extranodal NK-T-Cell 2Immunoblastic Lymphadenopathy 2Hematologic Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Waldenstrom Macroglobulinemia 1Retinoblastoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1

Interventions

Cyclophosphamide 15Antilymphocyte Serum 11fludarabine phosphate 10Cyclosporine 9Busulfan 9Peripheral Blood Stem Cell Transplantation 8Mycophenolic Acid 7Filgrastim 7Methotrexate 6Whole-Body Irradiation 5Melphalan 5fludarabine 4Radiotherapy 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Tacrolimus 3Psychiatric Rehabilitation 3Palliative Care 3Blood Specimen Collection 3sargramostim 2Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Polymerase Chain Reaction 2Injections 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Behavior Therapy 2Ascorbic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Myelodysplastic Syndromes × Cytarabine × Clear all
NCT07588360 2026-05-14

Haplo-Cord HSCT for AML/MDS

Fujian Medical University Union Hospital

Phase NA Recruiting
180 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02121418 2018-04-13

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

University of Washington

Phase NA Completed
12 enrolled 10 charts
Myeloid

Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡